THE EFFECT OF ETRASIMOD ON FECAL CALPROTECTIN AND HIGHSENSITIVITY C-REACTIVE PROTEIN: RESULTS FROM THE ELEVATE UC CLINICAL PROGRAM

被引：0
|
作者：
Jairath, Vipul
Rubin, David T.
Verstockt, Bram
Cekin, Ayhan Hilmi
Abreu, Maria T.
Lees, Charlie W.
Fellmann, Marc
Woolcott, John
Crosby, Catherine
Wu, Joseph
Bhattacharjee, Abhishek
Herman, David
Gu, Guibao
Siegmund, Britta
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1793
引用
收藏
页码：S816 / S816
页数：1
相关论文
共 50 条
  • [11] Etrasimod Demonstrated Consistent Efficacy and Safety as a Monotherapy or With Concomitant Use of Corticosteroids and/or 5-Aminosalicylates: Results From the ELEVATE UC Clinical Program
    Yarur, Andres J.
    Chiorean, Michael V.
    Allegretti, Jessica R.
    Cross, Raymond K.
    Ha, Christina
    Goetsch, Martina
    Rabbat, Christopher J.
    McDonnell, Aoibhinn
    Wu, Joseph
    Fragante, Naja
    Abbatemarco, Arcangelo M.
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S651 - S653
  • [12] What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?
    Ma, Christopher
    Battat, Robert
    Khanna, Reena
    Parker, Claire E.
    Feagan, Brian G.
    Jairath, Vipul
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2019, 38-39
  • [13] Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
    Schoepfer, Alain M.
    Beglinger, Christoph
    Straumann, Alex
    Trummler, Michael
    Renzulli, Pietro
    Seibold, Frank
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : 1851 - 1858
  • [14] Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
    Peyrin-Biroulet, Laurent
    Dubinsky, Marla C.
    Sands, Bruce E.
    Panes, Julian
    Schreiber, Stefan
    Reinisch, Walter
    Feagan, Brian G.
    Danese, Silvio
    Yarur, Andres J.
    D'Haens, Geert R.
    Goetsch, Martina
    Wosik, Karolina
    Keating, Michael
    Lazin, Krisztina
    Wu, Joseph
    Modesto, Irene
    McDonnell, Aoibhinn
    Bartolome, Lauren
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (08): : 1270 - 1282
  • [15] Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy
    Engstrom, Johanna
    Lonnkvist, Maria
    Befrits, Ragnar
    Ljung, Tryggve
    Diaz-Tartera, Hetzel
    Holst, Mikael
    Hellstrom, Per M.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1081 - 1088
  • [16] Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease?
    Ma, Christopher
    Battat, Robert
    Parker, Claire E.
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian Gordon
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (04) : 319 - 330
  • [17] Assessment of Serum C-Reactive Protein, Fecal Lactoferrin, and Fecal Calprotectin in Patients With Moderate-Severely Active Crohns Disease: Results From the IM UNITI Maintenance Study
    Sandborn, William
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Targan, Stephan
    Ghosh, Subrata
    Hanauer, Stephen B.
    GASTROENTEROLOGY, 2016, 150 (04) : S982 - S982
  • [18] FECAL IMMUNOCHEMICAL TEST, FECAL CALPROTECTIN, AND SERUM C-REACTIVE PROTEIN IN ASSESSMENT OF PATIENTS PRESENTING WITH CHRONIC LOWER BOWEL SYMPTOMS
    Chaemsupaphan, Thanaboon
    Yodmalai, Chatrawee
    Sattayalertyanyong, Onuma
    Subdee, Nichcha
    Permpim, Parinya
    Phaophu, Phutthaphorn
    Kaosombatwattana, Uayporn
    Pausawasdi, Nonthalee
    Charatcharoenwitthaya, Phunchai
    Pongprasobchai, Supot
    Riansuwan, Woramin
    Limsrivilai, Julajak
    GASTROENTEROLOGY, 2023, 164 (06) : S75 - S76
  • [19] Efficacy and Safety of Etrasimod in Patients With Ulcerative Colitis Stratified by Body Mass Index: A Post Hoc Analysis From the ELEVATE UC Clinical Program
    Yarur, Andres J.
    Long, Millie D.
    Torres, Joana
    Nandi, Neilanjan
    Cross, Raymond K.
    Abbatemarco, Arcangelo M.
    Blanco, David
    Niezychowski, Wojciech
    Crosby, Catherine M.
    Wu, Joseph
    Pradeep, Gokul
    Goetsch, Martina
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1026 - S1027
  • [20] Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
    Lichtenstein, Gary R.
    Allegretti, Jessica R.
    Loftus Jr, Edward, V
    Irving, Peter M.
    Banerjee, Rupa
    Charabaty, Aline
    Kuehbacher, Tanja
    Bananis, Eustratios
    Woolcott, John C.
    Dalam, Alexis B.
    Lazin, Krisztina
    Keating, Michael
    Mcdonnell, Aoibhinn
    Danese, Silvio
    INFLAMMATORY BOWEL DISEASES, 2025,
12345